Latest News in the pharma Industry

Policy & Regulation

Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda

Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda

15 Jan 2015

Read more 
Daiichi Sankyo Receives Approval in Japan for the Manufacture and Marketing of Methemoglobinemia Treatment Methylene Blue Injection 50 mg

Daiichi Sankyo Receives Approval in Japan for the Manufacture and Marketing of Methemoglobinemia Treatment Methylene Blue Injection 50 mg

9 Jan 2015

Read more 
Impax Pharmaceuticals Announces FDA Approval of Rytary Extended-Release Capsules for the Treatment of Parkinson's Disease

Impax Pharmaceuticals Announces FDA Approval of Rytary Extended-Release Capsules for the Treatment of Parkinson's Disease

9 Jan 2015

Read more 
Rx-360 Summary of EMA Guideline on Health Based Exposure Limited in Shared Facilities

Rx-360 Summary of EMA Guideline on Health Based Exposure Limited in Shared Facilities

31 Dec 2014

Read more 
First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis?

First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis?

30 Dec 2014

Read more 
Negative NICE Recommendation for Abraxane in Pancreatic Cancer

Negative NICE Recommendation for Abraxane in Pancreatic Cancer

30 Dec 2014

Read more 
Hospira Receives FDA Approval of Proprietary Analgesic Dyloject Injection

Hospira Receives FDA Approval of Proprietary Analgesic Dyloject Injection

30 Dec 2014

Read more 
Rx-360 Summary of FDA's Published Final Guidance for Industry: Specification of the Unique Facility Identifier System for Drug Establishment Registration

Rx-360 Summary of FDA's Published Final Guidance for Industry: Specification of the Unique Facility Identifier System for Drug Establishment Registration

29 Dec 2014

Read more 
Novo Nordisk Receives FDA Approval for Saxenda for the Treatment of Obesity

Novo Nordisk Receives FDA Approval for Saxenda for the Treatment of Obesity

24 Dec 2014

Read more 
BMS Receives Accelerated Approval of Opdivo (Nivolumab) from FDA

BMS Receives Accelerated Approval of Opdivo (Nivolumab) from FDA

23 Dec 2014

Read more 
Lynparza Approved by the FDA for the Treatment of Advanced Ovarian Cancer in Patients with Germline BRCA-Mutations

Lynparza Approved by the FDA for the Treatment of Advanced Ovarian Cancer in Patients with Germline BRCA-Mutations

22 Dec 2014

Read more 
Pozen’s Yosprala Receives Complete Response Letter from the FDA

Pozen’s Yosprala Receives Complete Response Letter from the FDA

22 Dec 2014

Read more